Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

N6809419F6054

Contract

Obligated and Ceiling

Obligated (net)
$887,473.92
Ceiling (potential value, not spending)
$887,473.92
Current value
$887,473.92
Gross positive obligations
$887,473.92

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
Awarding agency
Department of War · sub-agency 1700 · office N68094
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PIID
N6809419F6054
Parent vehicle (IDV PIID)
V797P7347A
Award type code
C
Actions
10 · Sep 25, 2019 to Aug 26, 2021
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History10

Award actions
DateFYModAction typeObligationCompany in company totals
Aug 26, 2021FY2021P00009M$0.00
—
Jul 14, 2021FY2021P00008M$220,000.00
—
May 11, 2021FY2021P00007M$0.00
—
Feb 8, 2021FY2021P00006C$133,494.79
—
Jan 26, 2021FY2021P00005C$133,494.78
—
Dec 8, 2020FY2021P00004C$0.00
—
Nov 17, 2020FY2021P00003C$66,747.39
—
Sep 8, 2020FY2020P00002G$0.00
—
Mar 3, 2020FY2020P00001B$0.00
—
Sep 25, 2019FY20190—$333,736.96
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.